Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Avastin
Pharma
Outlook wins FDA appeal after formal dispute proceedings
After a formal dispute resolution process, the FDA has decided that Outlook's eye drug candidate Lytenava has shown evidence of effectiveness.
Zoey Becker
May 27, 2026 8:26am
Amneal, BioCorRx accused of ‘false and misleading’ promotions
Apr 10, 2026 8:41am
FDA endorses Merck's Keytruda for the 1st time in ovarian cancer
Feb 11, 2026 10:04am
Outlook stock plummets as FDA again snubs wet AMD drug
Aug 28, 2025 10:55am
Akeso, Summit's PD-1 bispecific crushes Merck's Keytruda in study
Sep 8, 2024 11:30am
AZ charts new but uncertain path for Imfinzi in liver cancer
Jan 19, 2024 10:00am
